Kymera Therapeutics (KYMR) Revenue (2019 - 2026)
Kymera Therapeutics' Revenue came in at $65 million for Q2 2026, up 466.4% from $11.48 million a year earlier and up 89.1% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Revenue (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Kymera Therapeutics reported Revenue of $105 million, up 134.8% year-over-year; for FY2025, it was $39.21 million, down 16.7% from FY2024.
- Revenue carries a five-year compound annual growth rate of 2.9% (FY2020 to FY2025).
- Going back by year, Revenue was $47.07 million in FY2024 (-40.1%), $78.59 million in FY2023 (+67.8%), $46.83 million in FY2022 (-35.7%) and $72.83 million in FY2021 (+114.0%).
- The Q2 2026 figure represents the highest quarterly Revenue in data going back to Q3 2019.
- Year-over-year, Revenue increased in three of the last eight quarters, with growth averaging 48.6%.
- The fastest year-over-year change in Revenue over five years came in Q2 2026 (growth of 466.4%), and the weakest in Q4 2024 (a decline of 84.6%).
- Business Quant data shows KYMR's Revenue at $34.37 million (Q1 2026), $2.87 million (Q4 2025) and $2.76 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Kymera Therapeutics | 9.25 Bn | 6.56 Bn | - | 65.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 65.00 Mn |
| Mar 31, 2026 | 34.37 Mn |
| Dec 31, 2025 | 2.87 Mn |
| Sep 30, 2025 | 2.76 Mn |
| Jun 30, 2025 | 11.48 Mn |
| Mar 31, 2025 | 22.10 Mn |
| Dec 31, 2024 | 7.39 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Jun 30, 2024 | 25.65 Mn |
| Mar 31, 2024 | 10.29 Mn |
| Dec 31, 2023 | 47.89 Mn |
| Sep 30, 2023 | 4.73 Mn |
| Jun 30, 2023 | 16.51 Mn |
| Mar 31, 2023 | 9.47 Mn |
| Dec 31, 2022 | 16.14 Mn |
| Sep 30, 2022 | 9.55 Mn |
| Jun 30, 2022 | 11.51 Mn |
| Mar 31, 2022 | 9.62 Mn |
| Dec 31, 2021 | 15.28 Mn |
| Sep 30, 2021 | 20.34 Mn |
API Access
Kymera Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();